81
Participants
Start Date
October 30, 2020
Primary Completion Date
June 20, 2025
Study Completion Date
June 20, 2025
Intravenous injection of Tenecteplase and one dose of placebo tablet
Drug: Tenecteplase Tenecteplase administered as an intravenous injection (0.25 mg/kg body weigh; maximum 25 mg)
One tablet of Acetylsalicylic Acid and one dose of IV placebo
300 mg Acetylsalisylic acid
University Hospital Leuven, Leuven
University Hospital Antwerp, Antwerp
Aarhus University Hospital, Aarhus
Bispebjerg University Hospital, Copenhagen
Rigshospitalet University Hospital, Copenhagen
Helsinki University Hospital, Helsinki
Turku University Hospital, Turku
Kauno Klinikos Kaunas, Kaunas
Vilnius University Hospital, Vilnius
Haukeland University Hospital, Bergen
Vestre Viken Hospital Trust Drammen, Drammen
Østfold Hospital Trust Kalnes, Dept of Ophthalmology, Grålum
Helse Nord Trøndelag Trust, Namsos
Telemark Hospital Trust, Skien
St Olav University Hospital, Trondheim
Vestfold Hospital Trust, Tønsberg
Karolinska University Hospital, Stockholm
Oslo University Hospital, Oslo
Oslo University Hospital
OTHER